Acorda Therapeutics Interest Expense 2011-2026 | ACOR

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Acorda Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
31.5 M	30.2 M	30 M	30.6 M	21.9 M	21.6 M	18.7 M	16.5 M	15.5 M	9.29 M	2.17 M	1.88 M	3.57 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
31.5 M	1.88 M	18 M

Quarterly Interest Expense Acorda Therapeutics

2024-Q1	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
8.44 M	7.57 M	-	7.46 M	7.47 M	7.56 M	-	7.17 M	7.7 M	7.82 M	-	7.76 M	7.48 M	7.57 M	-	4.5 M	5.38 M	6.42 M	-	5.42 M	5.41 M	5.5 M	-	4.18 M	5.46 M	4.14 M	-	4.4 M	4.03 M	3.72 M	-	4.04 M	4.01 M	4.05 M	-	4.6 M	426 K	92 K	-	544 K	749 K	591 K	-	373 K	356 K	766 K	-	947 K	1.28 M	1.14 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
8.44 M	92 K	4.38 M

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
Aclaris Therapeutics ACRS	2.95 M	$ 3.01	3.79 %	$ 233 M	USA
AIkido Pharma AIKI	-5.79 M	-	1.93 %	$ 17.4 M	USA
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.1	1.31 %	$ 7.46 B	Australia
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	-5.01 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	476 K	-	-	$ 2.17 B	USA
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	9.29 M	$ 1.95	-1.27 %	$ 498 M	Britain
Aeglea BioTherapeutics AGLE	-20.7 M	-	-	$ 1.01 B	USA
Ascendis Pharma A/S ASND	65.5 M	$ 212.41	1.48 %	$ 5 B	Danmark
BioDelivery Sciences International BDSI	-6 K	-	-4.8 %	$ 255 M	USA
Athersys ATHX	103 K	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
BioVie BIVI	4.3 M	$ 1.14	0.49 %	$ 1.68 M	USA
Bellicum Pharmaceuticals BLCM	2.66 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	910 K	-	-7.31 %	$ 87 M	USA
Adaptimmune Therapeutics plc ADAP	-807 K	-	-15.15 %	$ 60.3 M	Britain
Can-Fite BioPharma Ltd. CANF	227 K	$ 0.2	6.23 %	$ 435 M	Israel
bluebird bio BLUE	16.4 M	-	-	$ 546 M	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Amphastar Pharmaceuticals AMPH	4.08 M	$ 26.71	-1.07 %	$ 1.29 B	USA
BeiGene, Ltd. BGNE	-12.6 M	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	2.65 M	-	-10.95 %	$ 876 K	USA
Arena Pharmaceuticals ARNA	4.16 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
Axon Enterprise AXON	286 M	$ 570.58	-0.27 %	$ 43.2 B	USA
Catalyst Biosciences CBIO	1.04 M	$ 11.67	0.56 %	$ 768 M	USA
Aytu BioScience AYTU	-512 K	$ 2.58	1.18 %	$ 16.2 M	USA
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA
ChromaDex Corporation CDXC	3 K	-	-0.88 %	$ 598 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	-7.26 M	$ 11.36	-2.41 %	$ 735 M	USA
Biogen BIIB	250 M	$ 176.12	-0.16 %	$ 25.6 B	USA
Certara CERT	-15.5 M	$ 8.78	-0.9 %	$ 1.41 B	USA
Cerevel Therapeutics Holdings CERE	10.6 M	-	-	$ 7.29 B	USA